# ALPHA & OMEGA SEMICONDUCTOR Ltd (AOSL) — Financial Analysis

**Exchange:** Nasdaq  
**Coverage as of:** 2026-Q2  
**Updated:** 2026-06-17  
**Tier:** Free primer (step 2 of 19)  
**Sibling pages:** /stocks/aosl/thesis · /memo/aosl

## Financial Snapshot

---
source: coverage-next-full
step: 04
ticker: AOSL
created: 2026-06-15
---

### Step 04 — Financial Quality
#### AOSL | Alpha & Omega Semiconductor Ltd

---

#### 1. Income Statement Quality Assessment

##### Revenue Recognition
AOSL recognizes revenue on shipment (distributor sell-in model) with adjustments for estimated returns and pricing credits. The distributor-heavy model (~70-75% of revenue through distribution) creates potential volatility: distributors may over-order during upcycles and destock aggressively in downturns, creating a "bullwhip" effect. The FY2023-FY2025 revenue stagnation was partially distribution-channel destocking. [S1]

**Quality judgment:** Sell-in revenue recognition is standard for the industry but introduces execution risk during transitions. No material revenue recognition issues identified in filings.

##### Gross Margin Adjustments
FY2025 gross margin of 23.1% includes the full burden of the AOSH JV consolidation. The JV carries significant fixed costs regardless of utilization. During the FY2023-FY2025 downturn, JV fab utilization was below optimal, creating overhead absorption headwinds. Adjusted for a normalized (75%+) utilization, gross margins would likely be 2-3 pp higher than reported. [S1, S2]

##### Non-Recurring Items
FY2025 net loss of ($97M) vs. operating loss of ($29M) implies ~$68M in below-the-line non-cash charges, primarily:
- Goodwill/long-lived asset impairment (estimated ~$65M) — triggered by sustained stock price/market cap compression
- The impairment appears triggered by market conditions, not operational deterioration of the JV specifically

**Quality judgment:** FY2025 GAAP losses are materially distorted by non-cash impairment. Normalized operating loss (~$29M) is a better proxy for recurring economic performance. [S1]

---

#### 2. Balance Sheet Quality

##### Assets

| Asset Category | FY2025 | Quality Assessment |
|----------------|--------|-------------------|
| Cash & Equivalents | ~$153M (FY2025-end), improved to ~$190M by Q3 FY2026 | High quality; no restricted cash issues |
| Accounts Receivable | ~$110-130M | Days Sales Outstanding ~60-70 days — normal for semi distribution channel |
| Inventories | ~$200-220M | Days Inventory Outstanding elevated during downturn; normalizing |
| PP&E (net) | ~$400-430M | Heavy due to JV fab; impairment charges reduced this modestly |
| Goodwill/Intangibles | Reduced post-impairment | Impairment taken; remaining goodwill should be low |
| Total Assets | ~$1.1-1.2B | |

**Inventory quality:** During the FY2023-FY2025 downturn, inventory levels were elevated as demand slowed faster than production. Inventory write-downs were modest (normal for silicon components with long shelf life vs. complex ICs). Normalizing inventory is a positive FCF catalyst. [S1, S2]

##### Liabilities & Capital Structure

| Item | FY2025 | Notes |
|------|--------|-------|
| Short-term debt | ~$29M | Credit facility drawdown |
| Long-term debt | ~$20-25M | Small JV-related facilities |
| Total Debt | ~$51M | Very manageable |
| Net Cash | ~$100-140M (FY2025), ~$160-190M (Q3 FY2026) | Solid; improving with CapEx normalization |
| Non-controlling interest | ~$50-80M | Minority stake in AOSH JV not owned by AOSL |

**Capital structure quality:** AOSL's balance sheet is a genuine strength. The company maintained net cash through the entire downturn cycle and avoided debt-financed distress. This is partly the founder-led discipline (Mike Chang historically conservative on leverage) and partly the inherent cash generation of a profitable business at mid-cycle. [S2]

---

#### 3. Cash Flow Statement Quality

##### Operating Cash Flow vs. Net Income

| FY | Net Income | OCF | OCF vs. NI | Quality |
|----|-----------|-----|-----------|---------|
| FY2022 | $102M | ~$95-110M | Close | Normal — SBC and working capital are modest adjustments |
| FY2023 | $13M | ~$70-80M | Higher | Working capital release (inventory draw-down) boosted OCF |
| FY2024 | ($7M) | ~$30-40M | Higher | Depreciation + working capital |
| FY2025 | ($97M) | ~($5-20M) | Higher | Impairment is non-cash add-back; OCF better than GAAP NI |

**FCF trajectory:**
- FY2022: CapEx peaked at ~$138M (JV fab investment) → FCF was negative despite strong earnings
- FY2023-FY2025: CapEx declining toward $40-60M range as JV investment program winds down
- FY2026E: FCF should turn positive as OCF recovers and CapEx stays low

**Quality judgment:** There are no red flags in the cash flow statement. The negative FCF period was driven by a deliberate capital investment program (JV expansion), not hidden operational deterioration. Free cash flow normalization is the bull case's core financial driver. [S1, S2]

---

#### 4. SBC and Dilution Assessment

| FY | SBC ($M) | SBC as % of Revenue | Diluted Shares (M) |
|----|----------|---------------------|---------------------|
| FY2022 | ~$29M | 4.0% | ~30.9M |
| FY2023 | ~$33M | 4.8% | ~30.7M |
| FY2024 | ~$36M | 5.5% | ~30.3M |
| FY2025 | ~$38M | 5.5% | ~29.5M |
| Q3 FY2026 | ~$9M (quarterly) | ~5% run-rate | ~29.8M |

SBC as a percentage of revenue (~5%) is moderate for a semiconductor company. Diluted share count has been declining modestly (buybacks offsetting SBC grants) — a mild positive. No concerning dilution trend. [S1]

---

#### 5. Adversarial Research Sweep

*Note: Earnings call transcripts not available (coverage-next-full path). Short seller reports and investigations researched via SEC filings and web search.*

##### Findings:

**i. Chongqing JV Opacity:** The AOSH joint venture is the most significant governance/transparency concern. While AOSL has consolidated the JV and provides more disclosure than a minority interest, the detailed JV operating economics (utilization rates, per-unit costs, transfer pricing) are not publicly disclosed. Investors must trust management's characterization of JV cost efficiency. This is a legitimate concern given the JV's material impact on gross margins. [S1]

**ii. Founder-Family CEO Transition:** The transition from founder Mike Chang to son Stephen Chang (March 2023) raises standard succession/nepotism questions. Governance checks: AOSL has 7/9 independent directors (78%), a lead independent director, and has passed say-on-pay consistently. No activist involvement. The transition appears orderly and the board has appropriate independence. [S3]

**iii. China Geopolitical Risk:** AOSL's Chongqing manufacturing base and significant China customer revenue (consumer electronics OEMs) create meaningful US-China trade risk. The 10-K explicitly lists trade restrictions, export controls, and tariffs as material risk factors. This is a real risk but is industry-wide and disclosed clearly. [S1]

**iv. NVIDIA Customer Concentration:** AOSL does not disclose customers >10% of revenue in its 10-Ks, but based on investor presentations (>150M DrMOS units expected, NVIDIA GB300 primary supply), NVIDIA-related revenue may be approaching or exceeding 10% of total sales in FY2026. Concentration risk in a single OEM/platform is a legitimate concern. [S4]

**v. No Short Reports or SEC Investigations Found:** Search of SEC EDGAR, litigation databases, and web sources found no material short seller campaigns, SEC enforcement actions, restatements, or ongoing investigations against AOSL. The company has a clean regulatory track record. [S5]

**Adversarial sweep conclusion:** AOSL's risk profile is dominated by business-model factors (JV opacity, China exposure, customer concentration) rather than governance failures or fraud indicators. The sweep found no red flags that would impair the fundamental thesis.

---

#### 6. Accounting Policy Notes

- **Revenue recognition:** ASC 606; sell-in to distributors; estimated variable consideration reserves
- **Inventory:** FIFO; no material write-downs detected in recent periods
- **JV consolidation:** AOSH consolidated at ~81%+ ownership; non-controlling interest carried on BS
- **Impairment testing:** Annual goodwill/long-lived asset test; FY2025 impairment reflects sustained market cap below book value
- **Pension/OPEB:** No material defined-benefit obligations
- **Leases:** ASC 842; operating leases primarily for office space; not material

---

#### Source Index

| Ref | Source |
|-----|--------|
| S1 | SEC 10-K FY2024 — Financial statements, MD&A, accounting policies |
| S2 | SEC 10-K FY2023 — Balance sheet, JV consolidation history |
| S3 | Proxy/governance data — AOSL_financials/proxy/governance_and_compensation.md |
| S4 | Investor Presentation Dec 2025 — AI revenue data |
| S5 | Web search — short seller reports, SEC enforcement search |

## Deeper Financial Analysis

The fundamental tier ($1.00) adds 8 dimensions not included here:

- Revenue Breakdown — segment revenue, geographic mix, product-line margins
- Financial Trends — QoQ momentum, leading indicators, inflection points
- Balance Sheet — debt structure, dilution risk, working capital dynamics
- Capital Allocation — ROIC, buyback cadence, reinvestment efficiency
- Earnings Analysis — beats/misses, guidance vs actuals, transcript highlights
- Competitive Positioning — market share, pricing power, peer benchmarks
- Industry Context — TAM, sector tailwinds/headwinds, regulatory backdrop

**API endpoint:** GET /api/v1/research/AOSL/fundamental

## Navigation

- Overview: /stocks/aosl
- Financials (this page): /stocks/aosl/financials
- Thesis: /stocks/aosl/thesis
- Investment Memo: /memo/aosl
- Coverage universe: /stocks